image description

Improve lead screening rates, health outcomes and HEDIS scores.

More compliance + enhanced parent and provider satisfaction = LeadCare® II

LeadCare II is the only blood lead testing system that makes it possible to test, educate and intervene, on-the-spot, in one visit. This accurate and quantitative diagnostic test takes only 3 minutes and can be done from the same fingerstick as a hemoglobin test.  

LeadCare II Benefits

image description

1 Fingerstick

Combines with mandated hemoglobin testing at the point of care.

image description

Enhanced Satisfaction

Convenient for parents. Easy for providers.

image description

Real-time Intervention

Doctor & parents act immediately, reducing impact on healthcare system.

image description

Best Practices

Increased compliance & improved HEDIS scores.

Reducing the impact of lead exposure

The annual economic cost of pediatric lead poisoning is $43 billion. Other childhood diseases with environmental causes, such as asthma and childhood cancer, are $2.0 and $0.3 billion, respectively.1

It is estimated that over 535,000 children in the U.S. have harmful blood lead levels.2
 
The American Academy of Pediatrics (AAP) recommends that managed care organizations fully cover the costs of lead screening and follow-up.3

Improve HEDIS scores.  Blood lead testing became a permanent HEDIS measure in 2009.  The National Committee for Quality Assurance (NCQA) reminds, “High blood lead levels have significant health implications that are often irreversible in children and lead to unnecessary medical expenses.”4

Organizations that have implemented on-site lead testing have seen dramatic improvement in compliance with mandated testing. 

Elevated blood lead levels have been associated with avoidable medical costs of $1,300 per child.Early intervention may save on expensive treatments later.

To learn more about using the LeadCare II system to improve compliance, contact us.

  1. Landrigan PJ, Clyde BS, Lipton JM, Fahs MC, Schwartz J. Environmental Pollutants and Disease in American Children: Estimates of Morbidity, Mortality and Costs for Lead Poisoning, Asthma, Cancer and Developmental Disabilities. Environ Health Perspect. July 2002: 110(7):721-728
  2. Wheeler, W. Blood Lead Levels in Children aged 1-5 years - US, 199-2010. Morbidity and Mortality Weekly Report. 2013;62(13):245-247.
  3. American Academy of Pediatrics, Committee on Environmental Health. Lead Exposure in Children:  Prevention, Detection, and Management. Policy Statement. Pediatrics. 2005; 116:1036-1046. Affirmed Jan 2009.
  4. NCQA News Release:  July 11, 2007. National Committee for Quality Assurance, Washington DC. www.ncqa.org/tabid/517/Default.aspx
  5. U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, National Quality Measures Clearinghouse. Lead Screening in Children:  percentage of children two years of age who had one or more capillary or venous lead blood tests for lead poisoning by their second birthday. 2010. http://qualitymeasures.ahrp.gov/content.aspx?id=32464 Accessed Jan 2012.

Success Stories

Point-of-Care Testing Radically Improves Compliance: “from near zero to 100%”

“Beyond improving screening rates dramatically and identifying children who need important follow-up care, we also find that the immediate results help us to empower parents to prevent future lead poisoning" notes Leslie Holbrook, Medical Office Manager
More Success Stories

Request More Information
* = Required

 Security code